- Home
- ALT vs NATH Comparison
ALT vs NATH Comparison
Compare ALT & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALT
- NATH
- Stock Information
- Founded
- ALT 1997
- NATH 1916
- Country
- ALT United States
- NATH United States
- Employees
- ALT N/A
- NATH N/A
- Industry
- ALT Biotechnology: Pharmaceutical Preparations
- NATH Restaurants
- Sector
- ALT Health Care
- NATH Consumer Discretionary
- Exchange
- ALT Nasdaq
- NATH Nasdaq
- Market Cap
- ALT 472.3M
- NATH 385.4M
- IPO Year
- ALT N/A
- NATH N/A
- Fundamental
- Price
- ALT $5.32
- NATH $94.80
- Analyst Decision
- ALT Strong Buy
- NATH
- Analyst Count
- ALT 8
- NATH 0
- Target Price
- ALT $21.00
- NATH N/A
- AVG Volume (30 Days)
- ALT 3.0M
- NATH 10.7K
- Earning Date
- ALT 05-08-2025
- NATH 02-06-2025
- Dividend Yield
- ALT N/A
- NATH 2.11%
- EPS Growth
- ALT N/A
- NATH 24.88
- EPS
- ALT N/A
- NATH 5.80
- Revenue
- ALT $20,000.00
- NATH $146,386,000.00
- Revenue This Year
- ALT N/A
- NATH N/A
- Revenue Next Year
- ALT N/A
- NATH N/A
- P/E Ratio
- ALT N/A
- NATH $16.34
- Revenue Growth
- ALT N/A
- NATH 6.83
- 52 Week Low
- ALT $5.14
- NATH $64.02
- 52 Week High
- ALT $11.16
- NATH $104.96
- Technical
- Relative Strength Index (RSI)
- ALT 39.42
- NATH 51.75
- Support Level
- ALT $5.60
- NATH $92.64
- Resistance Level
- ALT $6.16
- NATH $95.58
- Average True Range (ATR)
- ALT 0.35
- NATH 1.91
- MACD
- ALT 0.01
- NATH -0.36
- Stochastic Oscillator
- ALT 17.65
- NATH 60.71
About ALT Altimmune Inc.
Altimmune Inc is engaged in developing treatments for obesity and liver diseases. The Company's pipeline includes next-generation peptide therapeutics for obesity and non-alcoholic steatohepatitis (NASH) (for both, pemvidutide, formerly known as ALT-801), and for chronic hepatitis B (HepTcell). The Company is managed and operates as a single business focused on the research and development of treatments for various diseases and disorders, and vaccines.
About NATH Nathan's Famous Inc.
Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.